Complera Tablet, Film Coated
Product Images NDC 61958-1101

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Complera (NDC 61958-1101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gilead Sciences, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Complera 01)

FDA Label Image

Chemical Structure (Complera 02)

FDA Label Image

Chemical Structure (Complera 03)

FDA Label Image

Principal Display Panel (30 Tablet Bottle Label)

Principal Display Panel (30 Tablet Bottle Label)
COMPLERA tablets are a medication used to treat HIV. Each tablet contains a mixture of emtricitabine, ilpivirine, rilpivirine, and tenofovir disoproxil fumarate. The recommended storage temperature is 25 °C (77 °F), and the tablets should be kept in their original container. The package insert should be consulted for dosage and administration instructions. The tablets are manufactured by Gilead Sciences, Inc. in Canada.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.